Jan 26-2006 FDA approved

a) 21-938 for GIST
b) 21-968 fore renal cell carcinoma


1 Nishida T, Hirota S. 2000. Biological and clinical review of stromal tumors in the
gastrointestinal tract. Histol Histopathol 15(4): 1293-1301.
2 Miettinen M, Lasota J. 2001. Gastrointestinal stromal tumors - definition, clinical,
histological, immunohistochemical, and molecular genetic features and differential diagnosis.
Virchows Arch 438(1), 1-12.
3 Goettsch, WG, Bos, SD, Breekveldt-Postma, N, Casparie, M, Herings, RMC, Hogendoom,
PCW. 2005. Incidence of gastrointestinal stromal tumours is underestimated: Results ofa
nation-wide study. Eur J Ca 41: 2868-2872.
4 Roberts PJ, Eisenberg B. 2002. Clinical presentation of gastrointestinal stromal tumors and
treatment of operable disease. Eur J Cancer 38(Suppl. 5): S37-S38.
5 Miettinen M, Majidi M, Lasota J. 2002. Pathology and diagnostic criteria of gastrointestinal
stromal tumors (GISTs ): a review. Eur J Cancer 38(Suppl. 5): S39-S51.
6 Demetri GD, von Mehren M, Blanke CD, et al. 2002. Efficacy and safety of imatinib mesylate
in advanced gastrointestinal stromal tumors. New Engl J Med 347(7): 472-480.
7 Verweij J, Casali PG, Zalcberg J, et al. 2004. Progression-free survival in gastrnintestinal
stromal tumours with high-dose imatinib: randomised trial. Lancet 364(9440): 1127-1134.

1. Medical Research Council Renal Cancer Collaborative, Lancet 1999; 353: 14-17
2. Atkins MB et al, Clinical Cancer Research 2004;10:6342S-634
3. Negrier Set al, New England Journal of Medicine 1998; 338(18):1272-8
4. Vogelzang NJ et al, Journal of Clinical Oncology 1993; 11: 1809
s'. Escudier Bet al, Journal of Clinical Oncology l 999;17:2039-43
6. Nexavar Product Labeling accessed at
http:/ /www.fda.gov/cder/foi/label/2005/02 l 923lbl.pdf
7. A vastin Product Labeling accessed at
http://www.fda.gov/cdcr/foi/labcl/2005/l25085s$%lb1.pdf on September 2, 2005 and
December 16, 2005
8. Hurwitz, HI et al, New England Journal of Medicine 2005; 23(15): 3502-3508
9. Skillings JR et al, Proceedings of the American Society of Clinical Oncology 2005
abstract #3019
10. Scappaticci FA et al, Journal of Surgical Oncology 2005; 91(3):173-180
11. Faivre et al, .Journal of Clinical Oncology 2006; 24(1) published online ahead of print at
http://www.jco.org/cgi/reprint/JC0.2005.02.2194v 1